Edward Lain, MD
Dermatology · Austin, TXNPI 1124079306
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,593,222 of the $2,547,590 with a category attached, or 62.5%. It is spread thinly across 44 manufacturers, the largest accounting for just 12.5%. 2025 is the largest year on record at $629,999, 2.5 times the $248,990 reported in 2019. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,664 payments — averaging $956.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$319K
- Galderma Laboratories, L.p.$291K
- AbbVie$237K
- UCB, Inc.$200K
- Almirall LLC$194K
- Pfizer$176K
- plus $1.1M from 38 others
Across 1,212 payments — averaging $7959.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3.8M
- Novartis$1.4M
- Eli Lilly$639K
- Bausch Health US, LLC$458K
- Biofrontera Bioscience GmbH$422K
- Amgen$370K
- plus $2.6M from 28 others
What the payments were for
- Consulting fees$636,00125%
- Speaking & faculty fees$1,593,22263%
- Grants$82,5003%
- Travel & lodging$178,0157%
- Food & beverage$52,6292%
- Education$5,2120%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,547,590 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $109,544 |
| Tacrolimus | 51 | $5,149 |
| Clobetasol Propionate | 62 | $2,679 |
| Fluorouracil | 37 | $2,047 |
| Ofloxacin | 11 | $1,826 |
| Ketoconazole | 147 | $1,801 |
| Metronidazole | 14 | $914 |
| Doxycycline Hyclate | 36 | $695 |
| Triamcinolone Acetonide | 56 | $642 |
| Minocycline Hcl | 22 | $485 |
| Minoxidil | 43 | $466 |
| ValacyclovirValacyclovir Hcl | 22 | $463 |
| Hydrocortisone | 61 | $334 |
| Spironolactone | 13 | $324 |
| Mupirocin | 38 | $251 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Daniel CarrascoAustin$1.1M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- Ali ShahbazAustin$413K
- Jennifer GordonAustin$150K
- Madalyn NguyenAustin$127K
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.